Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Perfil Epidemiológico dos casos de hanseníase em São Luís-MA entre 2018 e 2021

Santos DA, Duarte Neto NC, Oliveira LDS, et al. Universidade Estadual de Alagoas. Diversitas Journal. 2023; 8 (1) : 0421-0430.
Download PDF
Publication

Clusters of risk for the occurrence of leprosy and disabilities in children under 15 years of age in Cuiabá: a geospatial study

Martoreli Júnior JF, Ramos ACV, Berra TZ, et al. FapUNIFESP (SciELO). Revista Brasileira de Epidemiologia. 2023;
Download PDF
Publication

Meaningful Engagement of Persons Affected by Leprosy in Research: An Exploration of Its Interpretation, Barriers, and Opportunities

de Groot L, van ‘t Noordende AT, Duck M, et al. MDPI AG. Tropical Medicine and Infectious Disease. 2023; 8 (1) : 52.
Download PDF
Publication

Hanseníase e vulnerabilidade: uma revisão de escopo

Jesus ILRD, Montagner MI, Montagner MÂ, et al. FapUNIFESP (SciELO). Ciência & Saúde Coletiva. 2023; 28 (1) : 143-154.
Download PDF
Publication

Effects of Citric Acid on the Healing Process of Chronic Wound due to Leprosy

Passos JRD, Sangaleti CT, Trincaus MR, et al. SAGE Publications. The International Journal of Lower Extremity Wounds. 2023;
Download PDF
Publication

Long-term presence of autoantibodies in plasma of cured leprosy patients

Yang X, Dong H, Kuang Y, et al. Springer Science and Business Media LLC. Scientific Reports. 2023;
Download PDF
Publication

Effect of adipose derived stromal vascular fraction on leprosy neuropathy: A Preliminary report

Sirait SP, Bramono K, Menaldi SL, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2023; 17 (1) : e0010994.
Download PDF
Publication

A compendium of indicators for monitoring and evaluating progress of the road map for neglected tropical diseases 2021–2030

World Health Organization . World Health Organization. 2022;
Download PDF
Publication

Análise do progresso da eliminação da hanseníase como problema de saúde pública no Brasil

Mota JMV, Silva APOD, Véras GCB, et al. Research, Society and Development. Research, Society and Development. 2023; 12 (1) : e2612139164.
Download PDF
Publication

Objective Structured Clinical Examination as a Training Tool for Leprosy in the Time of Elimination.

Bhardwaj A, Beniwal R. Indian journal of dermatology. 2022; 67 (4) : 480.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 197
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD